233 related articles for article (PubMed ID: 21743382)
21. Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients.
Lutsar I; Roffey S; Troke P
Clin Infect Dis; 2003 Sep; 37(5):728-32. PubMed ID: 12942409
[TBL] [Abstract][Full Text] [Related]
22. Oral voriconazole dose in children: one size does not fit all.
Goutelle S; Larcher R; Padoin C; Mialou V; Bleyzac N
Clin Infect Dis; 2010 Oct; 51(7):870; author reply 871. PubMed ID: 20809842
[No Abstract] [Full Text] [Related]
23. Pharmacokinetics of voriconazole following intravenous and oral administration and body fluid concentrations of voriconazole following repeated oral administration in horses.
Colitz CM; Latimer FG; Cheng H; Chan KK; Reed SM; Pennick GJ
Am J Vet Res; 2007 Oct; 68(10):1115-21. PubMed ID: 17916020
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetic evaluation of voriconazole treatment in critically ill patients undergoing continuous venovenous hemofiltration.
Radej J; Krouzecky A; Stehlik P; Sykora R; Chvojka J; Karvunidis T; Novak I; Matejovic M
Ther Drug Monit; 2011 Aug; 33(4):393-7. PubMed ID: 21654349
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic drug monitoring of voriconazole in a child with invasive aspergillosis requiring extracorporeal membrane oxygenation.
Brüggemann RJ; Antonius T; Heijst Av; Hoogerbrugge PM; Burger DM; Warris A
Ther Drug Monit; 2008 Dec; 30(6):643-6. PubMed ID: 19057370
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of concentration of voriconazole in aqueous humor after topical and oral administration in horses.
Clode AB; Davis JL; Salmon J; Michau TM; Gilger BC
Am J Vet Res; 2006 Feb; 67(2):296-301. PubMed ID: 16454636
[TBL] [Abstract][Full Text] [Related]
27. Monitoring plasma voriconazole levels following intravenous administration in critically ill patients: an observational study.
Myrianthefs P; Markantonis SL; Evaggelopoulou P; Despotelis S; Evodia E; Panidis D; Baltopoulos G
Int J Antimicrob Agents; 2010 May; 35(5):468-72. PubMed ID: 20188523
[TBL] [Abstract][Full Text] [Related]
28. Voriconazole pharmacokinetics and pharmacodynamics in children.
Neely M; Rushing T; Kovacs A; Jelliffe R; Hoffman J
Clin Infect Dis; 2010 Jan; 50(1):27-36. PubMed ID: 19951112
[TBL] [Abstract][Full Text] [Related]
29. Oral voriconazole versus intravenous low dose amphotericin B for primary antifungal prophylaxis in pediatric acute leukemia induction: a prospective, randomized, clinical study.
Mandhaniya S; Swaroop C; Thulkar S; Vishnubhatla S; Kabra SK; Xess I; Bakhshi S
J Pediatr Hematol Oncol; 2011 Dec; 33(8):e333-41. PubMed ID: 22042283
[TBL] [Abstract][Full Text] [Related]
30. An alternative approach to determine oral bioavailability of drugs that follow Michaelis-Menten elimination: a case study with voriconazole.
Verlindo de Araujo B; Farias da Silva C; Costa TD
Pharmacology; 2010; 86(3):163-7. PubMed ID: 20714206
[TBL] [Abstract][Full Text] [Related]
31. Voriconazole serum levels measured by high-performance liquid chromatography: a monocentric study in treated patients.
Gómez-López A; Cendejas-Bueno E; Cuesta I; García Rodríguez J; Rodríguez-Tudela JL; Gutiérrez-Altés A; Cuenca-Estrella M
Med Mycol; 2012 May; 50(4):439-45. PubMed ID: 22070341
[TBL] [Abstract][Full Text] [Related]
32. Plasma levels of voriconazole administered via a nasogastric tube to critically ill patients.
Mohammedi I; Piens MA; Padoin C; Robert D
Eur J Clin Microbiol Infect Dis; 2005 May; 24(5):358-60. PubMed ID: 15875225
[No Abstract] [Full Text] [Related]
33. [Level of evidence for therapeutic drug monitoring of voriconazole].
Hulin A; Dailly E; Le Guellec C;
Therapie; 2011; 66(2):109-14. PubMed ID: 21635857
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of voriconazole during continuous venovenous haemodiafiltration.
Fuhrmann V; Schenk P; Jaeger W; Miksits M; Kneidinger N; Warszawska J; Holzinger U; Kitzberger R; Thalhammer F
J Antimicrob Chemother; 2007 Nov; 60(5):1085-90. PubMed ID: 17855725
[TBL] [Abstract][Full Text] [Related]
35. Association of sustained high plasma trough concentration of voriconazole with the incidence of hepatotoxicity.
Suzuki Y; Tokimatsu I; Sato Y; Kawasaki K; Sato Y; Goto T; Hashinaga K; Itoh H; Hiramatsu K; Kadota J
Clin Chim Acta; 2013 Sep; 424():119-22. PubMed ID: 23747486
[TBL] [Abstract][Full Text] [Related]
36. Safety and pharmacokinetics of oral voriconazole in patients at risk of fungal infection: a dose escalation study.
Lazarus HM; Blumer JL; Yanovich S; Schlamm H; Romero A
J Clin Pharmacol; 2002 Apr; 42(4):395-402. PubMed ID: 11936564
[TBL] [Abstract][Full Text] [Related]
37. Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipients.
Trifilio S; Pennick G; Pi J; Zook J; Golf M; Kaniecki K; Singhal S; Williams S; Winter J; Tallman M; Gordon L; Frankfurt O; Evens A; Mehta J
Cancer; 2007 Apr; 109(8):1532-5. PubMed ID: 17351937
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of oral voriconazole in patients with cystic fibrosis.
Clifton IJ; Whitaker P; Metcalfe R; Phillip M; Shaw N; Conway SP; Peckham DG
J Antimicrob Chemother; 2011 Oct; 66(10):2438-40. PubMed ID: 21791443
[No Abstract] [Full Text] [Related]
39. Monitoring trough voriconazole plasma concentrations in haematological patients: real life multicentre experience.
Racil Z; Winterova J; Kouba M; Zak P; Malaskova L; Buresova L; Toskova M; Lengerova M; Kocmanova I; Weinbergerova B; Timilsina S; Rolencova M; Cetkovsky P; Mayer J
Mycoses; 2012 Nov; 55(6):483-92. PubMed ID: 22429709
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetic interaction between voriconazole and ciclosporin A following allogeneic bone marrow transplantation.
Groll AH; Kolve H; Ehlert K; Paulussen M; Vormoor J
J Antimicrob Chemother; 2004 Jan; 53(1):113-4. PubMed ID: 14657088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]